Unlisted
| Company Name | (주)엑셀세라퓨틱스 |
| English Name | Xcell Therapeutics Inc. |
| Business Reg. No. | 5348600230 |
| CEO | 이의일 |
| Address | 서울특별시 강남구 영동대로 333 동원빌딩 6층 |
| Industry | 기초 의약 물질 제조업 |
| Industry Code | 21100 |
| Established | Contact |
| Phone | 02-863-1331 |
| Website | www.xcell.media |
| Regular Employees | 63persons |
| Corp. Reg. No. | 1101115836767 |
Venture Certified
| 연구개발유형 | 2016-06-16 ~ 2018-06-15 | 20160107294 | 2016-06-16 |
| 연구개발유형 | 2018-06-16 ~ 2020-06-15 | 20180107426 | 2016-06-16 |
| 벤처투자유형 | 2020-06-16 ~ 2022-06-15 | 20200300737 | 2016-06-16 |
| 벤처투자유형 | 2022-06-16 ~ 2025-06-15 | 20220615010024 | 2016-06-16 |
| 벤처투자유형 | 2025-06-16 ~ 2028-06-15 | 20250618010003 | 2016-06-16 |
Revenue CAGR +37.7%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 19B | 11B | 10B |
| Operating Profit | -93B | -87B | -83B |
| Net Profit | -95B | -92B | -83B |
| Total Assets | 170B | 106B | 156B |
| Total Liabilities | 78B | 81B | 70B |
| Total Equity | 93B | 25B | 86B |
Operating Loss: Op. profit -93B
3 Consecutive Years of Net Loss
▲ 80.4%
▼ 9.7%
▲ 39.3%
▼ 58.7%
▲ 56.1%
| Name | Position | Role |
|---|---|---|
| 이의일 | 대표이사 | 대표 |
| NPS Subscribers | 63persons |
| CEO | 이의일 |
| Est. Avg. Annual Salary | 5,24010K (43710K/mo) |
| Hired (12 mo) | +0persons |
| Left (12 mo) | -3persons |
| Net Change (12 mo) | -3persons |
| NPS Join Date | 2015-09-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "서울특별시 강남구",
"ceo_name": "이의일",
"certificate": [
{
"cert_number": "20160107294",
"changes": "",
"disclosure_date": "2016-06-16",
"first_cert_date": "2016-06-16",
"no": "1",
"type": "연구개발유형",
"valid_period": "2016-06-16 ~ 2018-06-15"
},
{
"cert_number": "20180107426",
"changes": "",
"disclosure_date": "2018-06-18",
"first_cert_date": "2016-06-16",
"no": "2",
"type": "연구개발유형",
"valid_period": "2018-06-16 ~ 2020-06-15"
},
{
"cert_number": "20200300737",
"changes": "",
"disclosure_date": "2020-07-02",
"first_cert_date": "2016-06-16",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2020-06-16 ~ 2022-06-15"
},
{
"cert_number": "20220615010024",
"changes": "",
"disclosure_date": "2022-06-15",
"first_cert_date": "2016-06-16",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2022-06-16 ~ 2025-06-15"
},
{
"cert_number": "20250618010003",
"changes": "",
"disclosure_date": "2025-06-18",
"first_cert_date": "2016-06-16",
"no": "5",
"type": "벤처투자유형",
"valid_period": "2025-06-16 ~ 2028-06-15"
}
],
"company_name": "㈜엑셀세라퓨틱스",
"financials": {
"2022": {
"capital_stock": 4379707000,
"cost_of_sales": 2805124000,
"current_assets": 7160440000,
"current_liabilities": 5182437000,
"gross_profit": -1785090000,
"net_income": -8331061000,
"net_income_bs": -8331061000,
"non_current_assets": 8408605000,
"non_current_liabilities": 1826930000,
"non_operating_expenses": 212515000,
"non_operating_income": 172900000,
"operating_profit": -8291446000,
"revenue": 1020035000,
"sga_expenses": 6506357000,
"total_assets": 15569046000,
"total_equity": 8559678000,
"total_liabilities": 7009368000
},
"2023": {
"capital_stock": 4581836000,
"cost_of_sales": 2988502000,
"current_assets": 4392056000,
"current_liabilities": 5437789000,
"gross_profit": -1864603000,
"net_income": -9243547000,
"net_income_bs": -9243547000,
"non_current_assets": 6184597000,
"non_current_liabilities": 2642207000,
"non_operating_expenses": 701713000,
"non_operating_income": 130327000,
"operating_profit": -8672161000,
"revenue": 1123898000,
"sga_expenses": 6807558000,
"total_assets": 10576653000,
"total_equity": 2496658000,
"total_liabilities": 8079996000
},
"2024": {
"capital_stock": 5459231000,
"cost_of_sales": 3342159000,
"current_assets": 10506930000,
"current_liabilities": 4897039000,
"gross_profit": -1407815000,
"net_income": -9513101000,
"net_income_bs": -9513101000,
"non_current_assets": 6516494000,
"non_current_liabilities": 2862099000,
"non_operating_expenses": 492888000,
"non_operating_income": 282283000,
"operating_profit": -9302496000,
"revenue": 1934344000,
"sga_expenses": 7894681000,
"total_assets": 17023424000,
"total_equity": 9264286000,
"total_liabilities": 7759138000
}
},
"industry": "기초 의약 물질 제조업",
"investment": [
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2021-03-18"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2021-03-18"
},
{
"amount": "225,000,000",
"changes": "225,000,000",
"date": "2021-03-17"
},
{
"amount": "675,000,000",
"changes": "675,000,000",
"date": "2021-03-17"
},
{
"amount": "500,000,000",
"changes": "500,000,000",
"date": "2021-03-05"
},
{
"amount": "6,000,000,000",
"changes": "6,000,000,000",
"date": "2020-12-21"
},
{
"amount": "510,000,000",
"changes": "510,000,000",
"date": "2019-09-18"
},
{
"amount": "2,807,000,000",
"changes": "2,807,000,000",
"date": "2019-08-01"
},
{
"amount": "999,997,000",
"changes": "999,997,000",
"date": "2019-07-31"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2019-07-31"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2019-07-03"
},
{
"amount": "750,021,636",
"changes": "750,021,636",
"date": "2019-07-03"
},
{
"amount": "86,000,000",
"changes": "86,000,000",
"date": "2019-01-04"
},
{
"amount": "448,000,000",
"changes": "448,000,000",
"date": "2018-12-17"
},
{
"amount": "565,000,000",
"changes": "565,000,000",
"date": "2018-10-11"
}
],
"phone": "02-863-****",
"source": "pg_migration"
}{
"address": "서울특별시 강남구 영동대로",
"brno": "534860****",
"cappedWarning": false,
"companyName": "(주)엑셀세라퓨틱스",
"estimatedAvgAnnualSalary": 52403292,
"estimatedAvgMonthlySalary": 4366941,
"fetchedAt": "2026-03-05T18:21:06.972Z",
"industryCode": "999999",
"industryName": "BIZ_NO미존재사업장",
"joinDate": "20150901",
"last12MonthsHired": 0,
"last12MonthsLeft": 3,
"last12MonthsNetChange": -3,
"leaveDate": null,
"monthlyPensionAmount": 26136140,
"monthlyTrend": [
{
"lostSubscribers": 3,
"newSubscribers": 0,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6459621",
"status": "1",
"styleCode": "1",
"subscriberCount": 63,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | Public Data | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-26 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |